Regeneron Pharmaceuticals (REGN) Capital Expenditures (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.28% |
| Dec 31, 2025 | -47.19% |
| Sep 30, 2025 | 1,032.48% |
| Jun 30, 2025 | -122.02% |
| Mar 31, 2025 | 14.88% |
| Dec 31, 2024 | -50.68% |
| Sep 30, 2024 | 2,186.44% |
| Jun 30, 2024 | -86.78% |
| Mar 31, 2024 | -46.74% |
| Dec 31, 2023 | -35.83% |
| Sep 30, 2023 | 481.13% |
| Jun 30, 2023 | -157.69% |
| Mar 31, 2023 | 17.08% |
| Dec 31, 2022 | 6.81% |
| Sep 30, 2022 | -7.23% |
| Jun 30, 2022 | 8.32% |
| Mar 31, 2022 | -8.46% |
| Dec 31, 2021 | 16.29% |
| Sep 30, 2021 | -29.52% |
| Jun 30, 2021 | 152.67% |
| Mar 31, 2021 | -53.66% |
| Dec 31, 2020 | 5.35% |
| Sep 30, 2020 | 17.94% |
| Jun 30, 2020 | -23.63% |
| Mar 31, 2020 | 22.37% |
| Dec 31, 2019 | 14.22% |
| Sep 30, 2019 | 28.65% |
| Jun 30, 2019 | 27.32% |
| Mar 31, 2019 | -13.10% |
| Dec 31, 2018 | -19.49% |
| Sep 30, 2018 | -5.18% |
| Jun 30, 2018 | 41.06% |
| Mar 31, 2018 | -26.23% |
| Dec 31, 2017 | 80.44% |
| Sep 30, 2017 | 8.76% |
| Jun 30, 2017 | 8.70% |
| Mar 31, 2017 | -66.45% |
| Dec 31, 2016 | 26.87% |
| Sep 30, 2016 | -14.61% |
| Jun 30, 2016 | 33.38% |
| Mar 31, 2016 | -41.45% |
| Dec 31, 2015 | 21.68% |
| Sep 30, 2015 | -39.10% |
| Jun 30, 2015 | 110.13% |
| Mar 31, 2015 | -2.88% |
| Dec 31, 2014 | 47.35% |
| Sep 30, 2014 | 12.55% |
| Jun 30, 2014 | 9.33% |
| Mar 31, 2014 | -6.02% |
| Dec 31, 2013 | 117.65% |
| Sep 30, 2013 | -8.02% |
| Jun 30, 2013 | 62.49% |
| Mar 31, 2013 | 39.84% |
| Dec 31, 2012 | 47.95% |
| Sep 30, 2012 | -20.39% |
| Jun 30, 2012 | 16.44% |
| Mar 31, 2012 | -2.07% |
| Dec 31, 2011 | 26.87% |
| Sep 30, 2011 | -40.14% |
| Jun 30, 2011 | -32.94% |
| Mar 31, 2011 | -31.29% |
| Dec 31, 2010 | 45.96% |
| Sep 30, 2010 | -2.12% |
| Jun 30, 2010 | -0.71% |
| Mar 31, 2010 | 1.91% |
| Dec 31, 2009 | -0.07% |